Signature service
Build technology around a real healthcare problem.
Clinical, patient-experience, safety and NHS-context advice for AI companies, health-tech developers and maternal-health platforms.
Technology is only part of the intervention
Healthcare products enter complex systems. Their impact depends not only on technical performance, but on the problem they define, the data they privilege, the workflow they enter, the decisions they influence and the trust they earn from staff and patients.
I help product and leadership teams examine those questions early — and avoid treating commercial customer experience as interchangeable with patient experience. In healthcare, the purpose of listening is not repeat custom. It is safer care, reduced harm, better resolution, dignity and trust.
Who this is for
- AI and analytics companies entering NHS patient experience, quality or safety
- Feedback and survey platforms adapting commercial technology for healthcare
- Maternal-health apps developing antenatal or postnatal content and support
- Clinical documentation, communication or workflow products
- Start-ups preparing for pilots, partnerships, procurement or an advisory board
- Established providers refining an NHS proposition or moving into maternity
Advisory areas
Problem and use-case definition
Clarify whose problem the product solves, the decision it supports and how value will be demonstrated to patients, clinicians, operational leaders and buyers.
Clinical and patient-journey insight
Test assumptions against maternity pathways, real clinical work, women's support needs and the points where communication, escalation and continuity fail.
Patient-experience and safety intelligence
Explore how qualitative feedback can be collected, followed up, triangulated and translated into action — without flattening distressing experiences into sentiment scores.
Responsible AI and governance challenge
Identify clinical, ethical and operational risks including data quality, bias, explainability, consent, information governance, escalation, accountability and automation of sensitive interactions.
Content and pathway assurance
Review or develop patient-facing material for clinical accuracy, clarity, trauma-informed language, inclusivity, boundaries and alignment with the intended care pathway.
NHS readiness and positioning
Strengthen the NHS case for the product by connecting it to genuine service pressures, regulatory expectations, improvement priorities, implementation realities and credible outcomes.
Evidence, pilot and evaluation design
Define what needs to be learned before scaling and create a proportionate approach to feasibility, acceptability, safety, equity, workflow impact and outcomes.
Productised ways to work together
Clinical & NHS Reality Check
A focused independent review for an early proposition, product concept or planned healthcare use case. May include product demonstration, document review, a structured challenge session and a written decision brief.
Maternity Product & Pathway Review
A deeper assessment of how a product fits maternity journeys, workforce practice, patient needs and organisational responsibilities. May include journey mapping, stakeholder interviews, content or workflow review and prioritised recommendations.
NHS Patient Experience & Safety Proposition
For platforms moving beyond feedback collection towards a credible healthcare intelligence and improvement offer. May include NHS needs analysis, data-source and workflow mapping, safety use cases, outcome framework, positioning and pilot design.
Clinical Content Partnership
Development or review of antenatal, birth-preparation, partner, postnatal recovery or birth-trauma content, with recommendations for multidisciplinary review, service-user involvement and ongoing clinical governance.
Retained Clinical and Strategic Adviser
Regular independent input at product, pilot or partnership milestones. This can include advisory-board participation where the remit, responsibilities, time commitment, governance and remuneration are clearly defined.
What good advisory work produces
- A more precise and defensible use case
- Stronger clinical and patient relevance
- Earlier identification of risk and implementation barriers
- Clearer product priorities
- More credible NHS language and buyer proposition
- A pilot that tests meaningful questions
- Evidence claims matched to the maturity of the product
- Safer, more useful patient-facing content and interactions
Independence and boundaries
Advisory involvement does not constitute regulatory approval, clinical certification or endorsement of a product. Any public use of my name, credentials or contribution must be separately agreed. This protects both parties and ensures that clinical input is represented accurately.